TTD | Drug: D0Q3IS

Drug General Information
Drug ID	D0Q3IS
Former ID	DNCL002592
Drug Name	VB4-845
Drug Type	Antibody
Indication	Head and neck cancer [ICD9: 140-149, 140-229; ICD10:C07-C14, C32-C33]		Phase 2/3	[547580]
Company	Viventia Biotechnologies
Target and Pathway
Target(s)	Tumor-associated calcium signal transducer 1	Target Info		[544395]
References
Ref 547580	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017525)
Ref 544395	A bispecific EpCAM/CD133 targeted toxin is effective against carcinoma. Target Oncol. 2014 September; 9(3): 239-249.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information